AMYLIN PHARMACEUTICALS INC
- Biocon close to oral insulin deal with Bristol-Myers SquibbFour months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
- Bristol-Myers offers $3.5 bn for Amylin: ReportsShares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...
- Novo to launch Victoza in Japan in JuneDenmark's Novo Nordisk said it would launch its potential blockbuster drug Victoza in Japan this month.
- Load More